Comparison of serum protein profiles of Borrelia burgdorferi-positive Bernese Mountain Dogs and dogs of other breeds using MALDI-TOF technique.

The aim of the study was to compare the serum protein profile of Bernese Mountain Dogs (BMDs) reacting positive for Bb in snap testing with the serum protein profile of dogs of other breeds (healthy and with clinical borreliosis) using the MALDI time-of-flight (MALDI-TOF) technique. The observations included five groups of dogs. BMDs reacting positively to Bb in snap serological testing and showing symptoms of borreliosis (group 1), BMDs for which no borreliosis symptoms were determined but with seropositivity for Bb determined with snap serological tests (group 2), clinically healthy BMDs with no antibodies for Bb found in the serum (group 3), five dogs of different breeds, reacting positively in serological testing, in which borreliosis symptoms were observed (group 4), clinically healthy dogs of different breeds with negative reaction in tests towards Bb (group 5). A proteomic analysis demonstrated the presence of five identical protein fractions among all five groups. An additional two protein fractions of approximately 7.630 and 15.260 kDa were found in all the serum samples obtained from the dogs positive for borrelia in a snap test, both in those exhibiting symptoms of borreliosis, and seropositive BMDs not presenting symptoms of the disease. These two additional protein fractions may be used to differentiate between seropositive and seronegative B. burgdorferi dogs and may be considered a seropositivity marker, however, it cannot be used to differentiate between animals with the clinical form of the disease and those that are only seropositive.

Lyme disease in Bernese Mountain Dogs. Is it a real problem?

Borreliosis is the most frequently diagnosed tick-borne disease caused by spirochete bacteria belonging to the genus Borreliae - Borrelia burgdorferi sensu stricto (s.s.), Borrelia afzelii and Borrelia garinii. Clinical manifestations in dogs include fever, lameness, polyarthritis and glomerulonephritis. Diagnosis is mainly serological and is based on an immunoenzymatic test followed by a Western blot confirmatory test. Early treatment with antibiotics such as doxycycline or amoxicillin, for four weeks, usually reduces the risk of chronic disease. Tick control, including tick repellents, is highly reliable in preventing transmission. Vaccines are available to reduce transmission and the clinical manifestations of infection in dogs. Bernese Mountain Dogs are a breed that often test positive for antibodies against B. burgdorferi without showing any clinical symptoms of the disease. Quantitative determination of the immunoglobulin level for spirochetes has indicated that Bernese Mountain Dogs may have an increased susceptibility to Borrelia spp. infections of a hereditary nature.

Morphology of TiO2 nanotubes revealed through electron tomography.

In this work, scanning-transmission electron microscopy (STEM) tomography was successfully applied to characterize the three-dimensional structure of titanium oxide nanotubes prepared by the electrochemical anodization of the Ti substrate. The results provided detailed information about the morphology of nanotubes as well as insight into their growth. The segmentation of reconstructed images made it possible to estimate the surface area and volume of the nanotubes. The highest specific surface area was obtained for the lowest anodization voltage of 10V, and corresponds closely to that obtained using the porosimetry technique.

TiO2 nanotube composite layers as delivery system for ZnO and Ag nanoparticles - an unexpected overdose effect decreasing their antibacterial efficacy.

Enhancement of biocompatibility and antibacterial properties of implant materials is potentially beneficial for their practical value. Therefore, the use of metallic and metallic oxide nanoparticles as antimicrobial coatings components which induce minimized antibacterial resistance receives currently particular attention. In this work, TiO2 nanotubes layers loaded with ZnO and Ag nanoparticles were designed for biomedical coatings and delivery systems and evaluated for antimicrobial activity. TiO2 nanotubes themselves exhibited considerable and diameter-dependent antibacterial activity against planktonic Staphylococcus epidermidis cells but favored bacterial adhesion. Loading of nanotubes with moderate amount of ZnO nanoparticles significantly diminished S. epidermidis cell adhesion and viability just after 1.5h contact with modified surfaces. However, an increase of loaded ZnO amount unexpectedly altered the structure of nanoparticle-nanolayer, caused partial closure of nanotube interior and significantly reduced ZnO solubility and antibacterial efficacy. Co-deposition of Ag nanoparticles enhanced the antibacterial properties of synthesized coatings. However, the increase of ZnO quantity on Ag nanoparticles co-deposited surfaces favored the adhesion of bacterial cells. Thus, ZnO/Ag/TiO2 nanotube composite layers may be promising delivery systems for combating post-operative infections in hard tissue replacement procedures. However, the amount of loaded antibacterial agents must be carefully balanced to avoid the overdose and reduced efficacy.

A prospective randomized trial: a comparison of the analgesic effect and toxicity of 153Sm radioisotope treatment in monotherapy and combined therapy including local external beam radiotherapy (EBRT) among metastatic castrate resistance prostate cancer (mCRPC) patients with painful bone metastases.

Bone metastases in prostate cancer constitute the most frequent cause of systemic failure in treatment, which results in numerous complications and finally leads to patient's death. Pain is one of the first and most important clinical symptoms of bone metastases and can be found among more than 80% of patients. Therefore, the most analgetic effective and simultaneously the least toxic treatment is an important point of therapeutic management in this group of patients. The aim of this prospective clinical trial was a comparison of analgetic effectiveness and toxicity of monotherapy with 153Sm isotope to combined therapy (153Sm + EBRT) among patients diagnosed with multiple painful bone metastases due to CRPC (mCRPC). 177 patients with mCRPC were included into the prospective randomised clinical trial in which 89 patients were assigned to the 153Sm isotope monotherapy, while 88 patients were assigned to the combined therapy including 153Sm isotope therapy and EBRT. All patients were diagnosed (bone scan and X-ray or/and CT or/and MRI) with painful bone metastases (bone pain intensity >= 6 according to VAS classification). The following additional inclusion criteria were established: histologically confirmed adenocarcinoma of prostate, multifocal bone metastases, no prior chemotherapy or palliative radiotherapy to bone. All patients signed informed consent.The combination of the isotope therapy with EBRT was more effective analgetic treatment than isotope therapy alone. The highest pain decline was noticed in the first weeks after treatment termination. In the whole group, a total or partial analgesic effect was observed among 154 (87%) patients while among 23 (13%) patients there was a lack of analgesic effect or even pain intensification. The results of this clinical trial demonstrated that for patients with multiple mCRPC it is recommended to combine the 153Sm isotope therapy with local EBRT because of a greater analgetic effect. It is important to note that combined therapy did not intensify the toxicity of treatment.

Phase and electrical behaviour in Bi4NbO8.5.

A study of phase and electrical behaviour in the bismuth niobate, Bi(4)NbO(8.5), using x-ray and neutron powder diffraction, thermogravimetric analysis (TGA), x-ray photoelectron spectroscopy (XPS) and ac impedance spectroscopy is presented. Two polymorphs were identified in this composition, a tetragonal phase (type III), which can appear at temperatures above 800 °C and a pseudo-cubic phase (type II) evident at lower temperatures. The defect structure analysis of the type II phase is consistent with the existence of chains of niobate polyhedra, which facilitate electronic conduction at low temperatures. The appearance of the type III phase is strongly dependent on experimental conditions and TGA and XPS measurements suggest a likely association with change in oxygen stoichiometry.

Corrosion resistance of nanostructured titanium.

The present work reports results of studies of corrosion resistance of pure nano-Ti-Grade 2 after hydrostatic extrusion. The grain size of the examined samples was below 90 nm. Surface analytical technique including AES combined with Ar(+) ion sputtering, were used to investigate the chemical composition and thicknesses of the oxides formed on nano-Ti. It has been found that the grain size of the titanium substrate did not influence the thickness of oxide formed on the titanium. The thickness of the oxide observed on the titanium samples before and after hydrostatic extrusion was about 6 nm. Tests carried out in a NaCl solution revealed a slightly lower corrosion resistance of nano-Ti in comparison with the titanium with micrometric grain size.

Morphology and chemical characterization of Ti surfaces modified for biomedical applications.

The aim of the present work is to characterize in detail the chemical composition and morphology of titanium surfaces subjected to various environments. Modifications consisted of exposure of Ti to acidic, alkaline or polymer solutions. Such modifications result in chemical and/or morphological changes in the Ti surface. Special attention has been given to identifying the factors influencing cell adhesion and growth. SEM examinations provided morphological characterization of the Ti samples. Surface analytical techniques such as AES or XPS combined with Ar(+) ion sputtering allowed examination of the chemical properties of the Ti surface after chemical pretreatments and investigating the chemical composition of the Ti oxide layer. Raman spectroscopy investigations allowed determination of the crystalline phases of the Ti-oxide layers and characterization of the dextran-modified surface. The results show large differences in the morphology of Ti pretreated with different procedures whereas only minor differences in the chemistry of the surfaces were found. High-resolution Auger investigations have revealed that all the chemical modifications of Ti surfaces resulted in the formation of a titanium oxide layer. XPS confirmed that TiO(2) is the main component of the chemically modified Ti surface. The Raman spectroscopy investigations showed that the titanium surface with a dextran coating is rich in hydroxyl groups. All the surfaces investigated exhibit a hydrophilic character. The possible influence of various surface features on surface biocompatibility is discussed.

Microstructural and auger microanalytical characterization of Cu-Hf and Cu-Ti catalysts.

Degradation processes occurring at the surface and in the bulk of Cu-based amorphous alloys during cathodic hydrogen charging were used for promoting the catalytic activity of such alloys. These processes modifying the structure, composition, and morphology of the substrate proved to be useful methods for transforming Cu-Hf and inactive Cu-Ti amorphous alloy precursors into active and durable catalysts. Indeed, their catalytic activity for dehydrogenation of 2-propanol increased up to a conversion level of approximately 60% at selectivities to acetone of about 99% for Cu-Ti and to conversion of approximately 90% at selectivities of approximately 95% for Cu-Hf. Previous attempts carried out by aging in air or hydrogen charging from the gas phase resulted in a maximum conversion level up to 15% for Cu-Hf and up to 3% for Cu-Ti. High resolution Auger spectroscopy allowed changes occurring during the activation process to be identified, namely, the formation of small Cu particles on the HfO2 surface and the formation of highly porous particles containing mostly Cu and some Ti and O (Cu-Ti-O) on a Cu-Ti substrate. Differences in the chemistry and structure of both catalysts are discussed, and the implications for catalytic function are considered. A probable configuration of active sites on the Cu-Ti-O/Ti-O-Cu catalyst for dehydrogenation of 2-propanol is proposed.

Electron probe and auger electron microprobe characterization of modified Cu-based amorphous alloys.

Changes in morphology and local chemical composition due to various methods of modification of surfaces of Cu-Zr, Cu-Hf, and Cu-Ti amorphous alloys (caused by aging in air/dry corrosion or hydrogen charging) were investigated. These modification/activation procedures transform the original amorphous ribbons of low surface area into efficient and stable catalysts, due to the segregation of a distinct amount of Cu and the development of a large specific surface area of Cu on a ZrO x or HfO x support. It was found that aging in air resulted in the formation of a bilayer of rough copper (containing small Cu particles indispensable for catalysis) on top of a rather smooth oxide underlayer (ZrO x, HfO x ). Careful examination of the cross sections of the modified Cu-based ribbons revealed that, even after prolonged aging in air, only the first few microns of the surface layer was modified. Cu-Ti alloy was stable in air and did not undergo the expected modification. Hydrogenation followed by air exposure resulted in a disintegration of the ribbons into small pieces. Each piece was covered with many small Cu clusters 0.1-0.5 microm in diameter formed on an oxide underlayer. High-energy resolution Auger spectroscopy allowed identification of the underlayers (ZrO2, HfO2, or TiO x ), identification of small Cu clusters, determination of the degree of surface oxidation of them, and mapping of the surface to identify the Cu-covered and "naked" heavy metal.